Who Owns ZimVie Company?

Who Owns ZimVie?

ZimVie was bought by ARCHIMED and taken private in 2025, so control now sits with that private equity firm. The shift ended ZimVie's short life as a public company and changed how the brand is governed and funded.

Its 2024 spine sale and 2025 buyout left ZimVie focused on dental care, with ownership no longer spread across public shareholders. For a deeper view of the operating backdrop, see ZimVie Balanced Scorecard.

ZimVie founder and ownership history starts with a spin off from Zimmer Biomet, not with a classic startup founder model. Who owns ZimVie changed again in 2025, when funds managed by ARCHIMED took control in a cash deal valued at about 19.00 per share and roughly 730 million in equity value.

Founding path

ZimVie came from a corporate spin off, not a founder-led launch. Its early ownership sat inside Zimmer Biomet until the separation. That makes ZimVie ownership different from a family or founder controlled business.

Public market phase

Before the take private deal, ZimVie was a ZimVie public company. ZimVie shareholders included public investors, index funds, and other institutions. There was no single founder or parent company holding the stock.

Ownership shift in 2025

ARCHIMED became the ZimVie owner after the cash acquisition closed. That moved control away from public markets and into private hands. The ZimVie parent company now sits under funds managed by ARCHIMED.

Why it matters

Private ownership usually means tighter control over capital spending and strategy. It can also reduce disclosure compared with a listed ZimVie company profile. For investors, that changes how ZimVie stock ownership is assessed.

Key stakeholder now

The most important ZimVie major shareholders are now the ARCHIMED funds behind the buyout. Public ZimVie stock holders no longer govern the business. That makes ARCHIMED the main voice on direction and risk.

Related company context

For a broader view of the firm, see the Mission, Vision & Core Values of ZimVie. It helps connect the ownership change with the business identity and long term strategy.

ZimVie corporate ownership is now private, so exact percentages are not broadly disclosed, which is normal after a buyout. If you are asking is ZimVie publicly traded, the answer is no after the transaction. In practice, ZimVie investor relations now matters more for creditors, partners, and private owners than for public stock price discovery.

Ownership structure at a glance

Who owns ZimVie company stock today is mainly a private equity question, not a public market one. The 2025 deal valued the business at about 730 million in equity value and about 19.00 per share, which set the new control point.

• Spun off from Zimmer Biomet
• No founder controlled base
• Public shareholders held shares first
• ARCHIMED now controls ownership

ZimVie SWOT Analysis

• Organized to Save Time on Analysis
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

ZimVie ownership changed fast: Zimmer Biomet spun off ZimVie in 2022, the company sold its spine unit to H.I.G. Capital for 375 million in 2024, and ARCHIMED took ZimVie private in 2025. That sequence moved ZimVie from a public split-off to a narrower dental business and then into private control.

For people asking Who owns ZimVie, the answer depends on the date. ZimVie was a ZimVie public company until the ARCHIMED deal closed in 2025, so ZimVie shareholders shifted from public stock holders to private owner control. That matters for ZimVie investor relations, since less public disclosure usually means less visibility into ZimVie stock ownership breakdown, ZimVie institutional ownership, and ZimVie insider ownership. For context on strategy and product focus, see Growth Strategy of ZimVie.

Ownership and trust

ZimVie corporate ownership changed the brand story three times in three years. Each step narrowed the asset base and changed how customers and partners read the company.

• 2022 spin off sharpened accountability.
• 2024 sale cut noncore spine exposure.
• 2025 take private raised owner control.
• Private ownership can mean less disclosure.

ZimVie Ansoff Matrix

• Structured to Support Better Decisions
• Effortlessly Communicate Your Business Strategy
• Investor-Ready Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

ZimVie board of directors is no longer set by public-market voting after the ARCHIMED buyout closed. ZimVie is now a privately held asset, so the main influence sits with ZimVie ownership, the board it appoints, and management execution.

For investors asking who owns ZimVie company stock now, the answer is simple: ZimVie is no longer a ZimVie public company. Before the sale, ZimVie had a one-share-one-vote structure and no founder-controlled block, so influence came from the board, executives, and dispersed ZimVie shareholders; after the acquisition, that shifted to the new ZimVie parent company name and its control rights. For the deal context and the business mix, see Target Market of ZimVie.

Who Holds Real Influence Over ZimVie

ZimVie ownership is now concentrated, not spread across public holders. That makes control cleaner, but it also puts accountability on the sponsor, board, and management.

• ARCHIMED controls voting power
• Public shareholders lost board sway
• No dual-class founder structure existed
• Execution risk now sits with private owners

In a ZimVie company profile, this is the key shift in ZimVie company ownership structure: the old ZimVie stock ownership breakdown ended when the deal closed, and ZimVie institutional ownership tied to public markets disappeared. That also changes how ZimVie investor relations works, since ZimVie investor relations stock price access and ZimVie stock ownership data matter far less in a private setting than they did when ZimVie stock ownership was still public.

ZimVie merger and acquisition history matters because it explains the vote shift. ZimVie spin off from Zimmer Biomet created a public company, but the take-private deal removed the old public governance model and replaced it with sponsor control, so ZimVie major shareholders now answer to private equity logic, not market voting.

ZimVie Balanced Scorecard

• Clean, Modern, and Easy to Present
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

ZimVie ownership changed sharply from a public float to private control. After the 2022 spin off from Zimmer Biomet, the company narrowed further with the $375 million spine sale and then moved under ARCHIMED in 2025.

That shift matters for ZimVie company profile and brand trust. A public company has more disclosure, more ZimVie investor relations data, and wider ZimVie institutional ownership, while private ownership can improve speed and capital discipline but also cuts outside scrutiny. For anyone asking who owns ZimVie company stock today, the answer is no longer a broad market base but a private owner with tighter control over strategy and reporting.

From public float to private control

ZimVie was once a ZimVie public company with a wide shareholder base. After the 2025 deal, ZimVie stock holders gave way to a single private owner structure.

Why ownership affects credibility

Private ownership can support long term product work and tighter spending. It also means less public data, so trust depends more on the ZimVie board of directors and owner discipline.

Spine sale changed the mix

The $375 million spine sale was a key step in the ZimVie merger and acquisition history. It reduced complexity and pushed the business toward a narrower operating model.

Read the business model link

For context on how ownership links to earnings, see Revenue Streams & Business Model of ZimVie. That helps explain how ZimVie investor relations stock price moved as the company reshaped its portfolio.

For ZimVie major shareholders, the key trend is clear: the old mix of ZimVie shareholders, ZimVie stock ownership, and ZimVie institutional ownership no longer applies in the same way. The main question now is who is the owner of ZimVie and whether that ZimVie parent company name will keep funding product quality, clinical support, and innovation at the same level as the former ZimVie stock ownership model.

Brand credibility under private equity

ZimVie owner control can help if it protects quality and R and D. It can hurt if short term cost cuts weaken service, training, or product support.

What to watch next

Watch the ZimVie investor relations stock price history, disclosure quality, and any updates from the ZimVie board of directors. Those signals show how the new owner handles discipline and growth.

ZimVie VRIO Analysis

• Designed for Fast Business Analysis
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔